PTSD Functional Recovery Program
A therapeutic service combining MDMA-assisted therapy with functional impairment tracking to return severe PTSD patients to the workforce.
Concept
This service focuses not just on the reduction of PTSD symptoms (CAPS-5 scores), but on the reduction of 'functional impairment' as measured by the Sheehan Disability Scale (SDS). By utilizing the high efficacy of MDMA-assisted therapy, the program targets the 'breakthrough' potential of the treatment to move patients from disability to employment.
Why now
Paper [2] provides strong evidence from a phase 3 trial that MDMA-assisted therapy significantly decreases the SDS total score (P = 0.0116), meaning it doesn't just make patients feel better—it makes them more functional in their daily lives. This creates a commercial wedge for a program focused on 'functional recovery' rather than just 'symptom management'.
AI assessment
A high-potential clinical service that pivots from symptom reduction to economic productivity, though it faces significant regulatory and operational hurdles.
- Evidence strength 4/5
- The idea is directly grounded in a Phase 3 clinical trial showing statistically significant improvements in both CAPS-5 and SDS scores.
- Market pull 5/5
- The VA and insurance providers have a massive financial incentive to move patients from long-term disability payments back into the workforce.
- Novelty & moat 3/5
- While the therapy is novel, the 'functional recovery' framing is a business model shift rather than a technical innovation.
- Feasibility 2/5
- Implementation is heavily gated by FDA approval and the complex legal requirements of administering Schedule I substances.
- Wedge clarity 4/5
- Focusing on the Sheehan Disability Scale as a metric for workforce reentry provides a sharp, quantifiable value proposition for payers.
- Simplicity / focus 5/5
- The product is a single, focused therapeutic program with a clear objective: functional recovery.
Scored by AI against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity). A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Who benefits
- Department of Veterans Affairsorganization
Veterans with severe PTSD often struggle with functional disability; a program that improves SDS scores directly helps them reintegrate into society.
- U.S. Department of Veterans Affairsorganization
Would benefit from a high-efficacy treatment that reduces the disability burden and functional impairment of veterans with severe PTSD.
- First Responders (Police/Firefighters)individual
Individuals in high-trauma professions who need to return to duty but suffer from severe, comorbid PTSD.
Reducing long-term disability claims for severe PTSD by utilizing a high-efficacy, short-term intervention.
Research it builds on
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 studyJennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein et al. · 2021 · 968 citationsAll ideas from this paper →
Related ideas
- Psychedelic-Integrated Clinical Pathway (PICP) Certification
A standardized clinical certification and operational framework for mental health clinics to integrate high-dose psilocybin and MDMA into psychiatric workflows. The framework focuses on manualized therapy protocols, cost-effectiveness modeling, and specialized clinician training to bridge the gap between clinical trials and real-world implementation.
same research - Psychedelic-Integrated Therapy Certification for Clinicians
A professional certification program for clinicians to deliver psychedelic-assisted therapy, focusing on the critical preparatory and integrative psychological frameworks. The program emphasizes ethical safeguards and personalized care to manage the heightened suggestibility and vulnerability of patients during psychedelic experiences.
same research - Psychedelic-Integrated Therapy Certification
A professional certification program that trains licensed clinicians in the delivery of psychedelic-assisted psychotherapy. The program focuses on both standardized manualized protocols and flexible, transdiagnostic frameworks to ensure patient safety and clinical efficacy.
same research - PTSD Recovery Accelerator
A high-efficacy treatment program for severe PTSD combining MDMA-assisted therapy with functional impairment recovery tracking.
same research - MBCT Relapse Prevention Tracker
A digital therapeutic tool that combines mindfulness exercises with cognitive restructuring to reduce depression relapse rates.
- Relapse-Prevention Mindfulness Companion
A specialized digital therapeutic tool designed specifically for patients in remission from clinical depression to prevent relapse through structured MBCT (Mindfulness-Based Cognitive Therapy) exercises.